C07D 209/46
With an oxygen atom in position 1
Official title: with an oxygen atom in position 1
C07D209/46 (With an oxygen atom in position 1) appears on 474 US grants and 481 published applications in this corpus.
Search patents in C07D- Granted patents
- 474
- Published applications
- 481
- Assignees
- 280
- Inventors
- 1,477
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 3 | 0 |
| 1978 | 9 | 0 |
| 1979 | 3 | 0 |
| 1980 | 2 | 0 |
| 1981 | 6 | 0 |
| 1982 | 4 | 0 |
| 1983 | 6 | 0 |
| 1984 | 4 | 0 |
| 1985 | 8 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 3 | 0 |
| 1991 | 9 | 0 |
| 1992 | 5 | 0 |
| 1993 | 10 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 5 | 0 |
| 1997 | 9 | 0 |
| 1998 | 8 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 6 | 7 |
| 2002 | 5 | 9 |
| 2003 | 9 | 12 |
| 2004 | 7 | 18 |
| 2005 | 9 | 22 |
| 2006 | 10 | 24 |
| 2007 | 7 | 21 |
| 2008 | 16 | 29 |
| 2009 | 20 | 32 |
| 2010 | 19 | 26 |
| 2011 | 25 | 30 |
| 2012 | 24 | 26 |
| 2013 | 17 | 13 |
| 2014 | 22 | 18 |
| 2015 | 11 | 19 |
| 2016 | 19 | 21 |
| 2017 | 27 | 22 |
| 2018 | 10 | 13 |
| 2019 | 10 | 17 |
| 2020 | 13 | 21 |
| 2021 | 11 | 13 |
| 2022 | 7 | 14 |
| 2023 | 14 | 15 |
| 2024 | 8 | 16 |
| 2025 | 7 | 12 |
| 2026 | 7 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 4-Methoxy-2-phenethyl isoindoline-1-one derivative and composition for treating neurological diseases, comprising same11 Aug 2026US 12,703,686 B2Chungbuk National University Industry-Academic Cooperation Foundation
- Bisphenols bearing pendant clickable norbornenyl group and polymers therefrom7 Jul 2026US 12,673,917 B2Council of Scientific and Industrial Research
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Histone deacetylase inhibitors26 May 2026US 12,637,433 B2The University of Queensland
- Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors17 Mar 2026US 12,581,252 B2D. E. Shaw Research, LLC
- 1-oxoisoindolin-2-yl amide activators of vcp and derivatives thereof8 Oct 2026US 2026/0308122 A1
- Compounds for treating cancer1 Oct 2026US 2026/0297066 A1Genesis Molecular AI, Inc.
- Catalyst for sp3-carbon-hydrogen-bond primary amination reaction, and method for preparing primary amine compound13 Aug 2026US 2026/0234096 A1West China Second University Hospital, Sichuan University
- Negative allosteric modulators of metabotropic glutamate receptor 26 Aug 2026US 2026/0226019 A1Vanderbilt University
- Pi3k-alpha inhibitors and methods of use thereof16 Jul 2026US 2026/0205746 A1D. E. Shaw Research, LLC
Most cited
By later US patents
- Cyclic amides171US 5,698,579 ACelgene Corporation · 1997
- Cyclic amides169US 5,877,200 ACelgene Corporation · 1999
- Glutaramide diuretic agents156US 5,030,654 APfizer Inc. · 1991
- Enzyme modulators and treatments151US 8,163,756 B2Deciphera Pharmaceuticals, LLC · 2012
- Substituted phenethylsulfones and method of reducing TNF.alpha. levels136US 6,020,358 ACelgene Corporation · 2000